Daniel H Fulkerson

Dr. Daniel H Fulkerson


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MWMark M. Walsh
Mark M. Walsh
EMErnest Moore
Ernest Moore
HMHunter B. Moore
Hunter B. Moore
STScott Gerard Thomas
Scott Gerard Thomas
HKHau Kwaan
Hau Kwaan
QTQuincy Tran
Quincy Tran
This narrative review explores the pathophysiology, geographic variation, and historical developments underlying the selection of fixed ratio versus whole blood resuscitation for hemorrhaging trauma patients. We also detail a physiologically driven and goal-directed alternative to fixed ratio and whole blood, whereby viscoelastic testing guides the administration of blood components and factor concentrates to the severely bleeding trauma patient. The major studies of each resuscitation method are highlighted, and upcoming comparative trials are detailed.

28 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JBJamie L. Bradbury
Jamie L. Bradbury
STScott Gerard Thomas
Scott Gerard Thomas
Nikki SorgNikki Sorg
Nikki Sorg
NMNicolas Mjaess
Nicolas Mjaess
MBMargaret Berquist
Margaret Berquist
SSSherry Sixta
Sherry Sixta
A unique coagulopathy often manifests following traumatic brain injury, leading the clinician down a difficult decision path on appropriate prophylaxis and therapy. Conventional coagulation assays—such as prothrombin time, partial thromboplastin time, and international normalized ratio—have historically been utilized to assess hemostasis and guide treatment following traumatic brain injury. However, these plasma-based assays alone often lack the sensitivity to diagnose and adequately treat coagulopathy associated with traumatic brain injury. Here, we review the whole blood coagulation assays termed viscoelastic tests and their use in traumatic brain injury. Modified viscoelastic tests with platelet function assays have helped elucidate the underlying pathophysiology and guide clinical decisions in a goal-directed fashion. Platelet dysfunction appears to underlie most coagulopathies in this patient population, particularly at the adenosine diphosphate and/or arachidonic acid receptors. Future research will focus not only on the utility of viscoelastic tests in diagnosing coagulopathy in traumatic brain injury, but also on better defining the use of these tests as evidence-based and/or precision-based tools to improve patient outcomes.

23 February 2010 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
DFDaniel H Fulkerson
Daniel H Fulkerson
JVJason M. Voorhies
Jason M. Voorhies
SMShannon P. McCanna
Shannon P. McCanna
TPTroy D. Payner
Troy D. Payner
TLThomas J. Leipzig
Thomas J. Leipzig
THTerry G. Horner
Terry G. Horner

9 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MWMark M. Walsh
Mark M. Walsh
MFMark D. Fox
Mark D. Fox
EMErnest Moore
Ernest Moore
JJJeffrey Johnson
Jeffrey Johnson
Connor BunchConnor Bunch
Connor Bunch
MWMark M. Walsh
Mark M. Walsh
The reduction in the blood supply following the 2019 coronavirus pandemic has been exacerbated by the increased use of balanced resuscitation with blood components including whole blood in urban trauma centers. This reduction of the blood supply has diminished the ability of blood banks to maintain a constant supply to meet the demands associated with periodic surges of urban trauma resuscitation. This scarcity has highlighted the need for increased vigilance through blood product stewardship, particularly among severely bleeding trauma patients (SBTPs). This stewardship can be enhanced by the identification of reliable clinical and laboratory parameters which accurately indicate when massive transfusion is futile. Consequently, there has been a recent attempt to develop scoring systems in the prehospital and emergency department settings which include clinical, laboratory, and physiologic parameters and blood products per hour transfused as predictors of futile resuscitation. Defining futility in SBTPs, however, remains unclear, and there is only nascent literature which defines those criteria which reliably predict futility in SBTPs. The purpose of this review is to provide a focused examination of the literature in order to define reliable parameters of futility in SBTPs. The knowledge of these reliable parameters of futility may help define a foundation for drawing conclusions which will provide a clear roadmap for traumatologists when confronted with SBTPs who are candidates for the declaration of futility. Therefore, we systematically reviewed the literature regarding the definition of futile resuscitation for patients with trauma-induced hemorrhagic shock, and we propose a concise roadmap for clinicians to help them use well-defined clinical, laboratory, and viscoelastic parameters which can define futility.


Verified
Journal Article
Open access
PDF file
Mahmoud Al-FadhlMahmoud Al-Fadhl
Mahmoud Al-Fadhl
MKMarie Nour Karam
Marie Nour Karam
JCJenny Chen
Jenny Chen
SZSufyan K. Zackariya
Sufyan K. Zackariya
MLMorgan C. Lain
Morgan C. Lain
MWMark M. Walsh
Mark M. Walsh
This review explores the concept of futility timeouts and the use of traumatic brain injury (TBI) as an independent predictor of the futility of resuscitation efforts in severely bleeding trauma patients. The national blood supply shortage has been exacerbated by the lingering influence of the COVID-19 pandemic on the number of blood donors available, as well as by the adoption of balanced hemostatic resuscitation protocols (such as the increasing use of 1:1:1 packed red blood cells, plasma, and platelets) with and without early whole blood resuscitation. This has underscored the urgent need for reliable predictors of futile resuscitation (FR). As a result, clinical, radiologic, and laboratory bedside markers have emerged which can accurately predict FR in patients with severe trauma-induced hemorrhage, such as the Suspension of Transfusion and Other Procedures (STOP) criteria. However, the STOP criteria do not include markers for TBI severity or transfusion cut points despite these patients requiring large quantities of blood components in the STOP criteria validation cohort. Yet, guidelines for neuroprognosticating patients with TBI can require up to 72 h, which makes them less useful in the minutes and hours following initial presentation. We examine the impact of TBI on bleeding trauma patients, with a focus on those with coagulopathies associated with TBI. This review categorizes TBI into isolated TBI (iTBI), hemorrhagic isolated TBI (hiTBI), and polytraumatic TBI (ptTBI). Through an analysis of bedside parameters (such as the proposed STOP criteria), coagulation assays, markers for TBI severity, and transfusion cut points as markers of futilty, we suggest amendments to current guidelines and the development of more precise algorithms that incorporate prognostic indicators of severe TBI as an independent parameter for the early prediction of FR so as to optimize blood product allocation.